Maladie de Hodgkin : faut-il sélectionner des patients à haut risque et intensifier la chimiothérapie ? = Hodgkin's disease: high-risk patients selection for chemotherapy intensification?CARDE, P.Bulletin du cancer. 1995, Vol 82, Num 8, pp 637-649, issn 0007-4551Article

Hodgin's disease. I: Identification and classificationCARDE, P.BMJ. British medical journal (International ed.). 1992, Vol 305, Num 6845, pp 99-102, issn 0959-8146Article

Hodgkin's lymphoma. II : Treatment and delayed morbidityCARDE, P.BMJ. British medical journal (International ed.). 1992, Vol 305, Num 6846, pp 173-176, issn 0959-8146Article

EFFECT OF CIS-DICHLORODIAMMINE PLATINUM II AND X-RAYS ON MAMMALIAN CELL SURVIVALCARDE P; LAVAL F.1981; INT. J. RADIAT. ONCOL., BIOL., PHYS.; ISSN 0360-3016; USA; DA. 1981; VOL. 7; NO 7; PP. 929-933; BIBL. 20 REF.Article

Chemotherapy of Hodgkin's diseaseCARDE, P.Nouvelle revue française d'hématologie. 1990, Vol 32, Num 2, pp 169-173, issn 0029-4810, 5 p.Article

ASSOCIATIONS ENTRE LES RADIATIONS IONISANTES ET CERTAINS ANTIMITOTIQUES: EFFETS AU NIVEAU CELLULAIRELAVAL F; CARDE P; MICHEL S et al.1981; BULL. CANCER; ISSN 0007-4551; FRA; DA. 1981; VOL. 68; NO 2; PP. 116-120; ABS. ENG; BIBL. 14 REF.Article

Maladie de Hodgkin : pourquoi faut-il la radiothérapie dans les stades étendus III-IV ? = Hodgkin's disease : Why is irradiation needed in advanced stages III-IV?CARDE, P.Cancer radiothérapie. 1999, Vol 3, pp 137s-141s, issn 1278-3218, SUP1Conference Paper

Le lymphome splénique à lymphocyte villeux : mise au point = Splenic lymphoma with villous lymphocytes : a reviewCHAHINE, A; CARDE, P.Cahiers d'oncologie. 1995, Vol 4, Num 4, pp 143-145, issn 0941-3804Article

Diagnostic proceduresCARDE, P.Baillière's clinical haematology. 1996, Vol 9, Num 3, pp 479-501, issn 0950-3536Article

Facteurs pronostiques et traitements des formes localisées de la maladie de Hodgkin : Maladie de Hodgkin = Prognostic factors and treatments of localized Hodgkin's disease : Hodgkin's diseaseCARDE, P; COSSET, J.-M.La Revue du praticien (Paris). 1998, Vol 48, Num 10, pp 1075-1081, issn 0035-2640Article

Who are the high-risk patients with Hodgkin's disease ?CARDE, P.Leukemia. 1996, Vol 10, pp S62-S68, issn 0887-6924, SUP2Conference Paper

La chimiothérapie en perfusion intraveineuse prolongée: revue générale des bases théoriques et résultats = Continuous intravenous infusion of chemotherapy: theorical aspects and resultsGANEM, G; CARDE, P; GOUYETTE, A et al.Bulletin du cancer. 1985, Vol 72, Num 6, pp 491-505, issn 0007-4551Article

LEIOMYOSARCOME DE LA VEINE CAVE INFERIEURE SUS-RENALE. CHIMIOTHERAPIE ET ANASTOMOSE VEINEUSE CHIRURGICALE RENORENALE POUR LA CONSERVATION DU REIN DROITCARDE P; ELIAS D; BREIL P et al.1983; PRESSE (LA) MEDICALE (1983); ISSN 512281; FRA; DA. 1983; VOL. 12; NO 4; PP. 242Article

CELL-MEDIATED IMMUNE RESPONSIVENESS OF PATIENTS WITH ACUTE LYMPHOCYTIC LEUKEMIA IN REMISSIONOLDHAM RK; WEINER RS; MATHE G et al.1976; INTERNATION. J. CANCER; SWITZ.; DA. 1976; VOL. 17; NO 3; PP. 326-337; ABS. FR.; BIBL. 1 P. 1/2Article

Inhibiteurs de l'hématopoièse : de la physiologie à la thérapeutique. Discussion = Inhibitors of hematopoiesis: from physiology to therapyCARDE, P; GUIGON, M; BLANCHER, G et al.Bulletin de l'Académie nationale de médecine. 1994, Vol 178, Num 5, pp 793-806, issn 0001-4079Article

Early response to chemotherapy: a surrogate for final outcome of Hodgkin's disease patients that should influence initial treatment length and intensity?CARDE, P; KOSCIELNY, S; BONVIN, N et al.Annals of oncology. 2002, Vol 13, pp 86-91, issn 0923-7534, SUP1Conference Paper

Le rôle de la radiothérapie dans les formes localisées de maladie de Hodgkin en 1999 : limitations et perspectives = The role of radiation therapy for limited stage (I and II) Hodgkin's disease : limitations and perspectivesCOSSET, J. M; FERME, C; HENRY-AMAR, M et al.Cancer radiothérapie. 1999, Vol 3, Num 2, pp 112-118, issn 1278-3218Article

VIP (etoposide, ifosfamide and cisplatinum) as a salvage intensification program in relapsed or refractory Hodgkin's diseaseRIBRAG, V; NASR, F; PICO, J. L et al.Bone marrow transplantation (Basingstoke). 1998, Vol 21, Num 10, pp 969-974, issn 0268-3369Article

Clinical staging versus laparotomy and combined modality with MOPP versus ABVD in early-stage Hodgkin's disease : the H6 twin randomized trials from the European organization for research and treatment of cancer lymphoma cooperative groupCARDE, P; HAGENBEEK, A; SOMERS, R et al.Journal of clinical oncology. 1993, Vol 11, Num 11, pp 2258-2272, issn 0732-183XArticle

Phase II study of cytarabine in Hodgkin's diseaseTHOMAS, J; DE PAUW, B; HAGENBEEK, A et al.European journal of cancer (1990). 1992, Vol 28A, Num 4-5, pp 857-859, issn 0959-8049Article

Séraspénide (acétylSDKP) : étude en phase I-II d'un inhibiteur de l'hématopoïèse la protégeant de la toxicité de monochimiothérapies aracytine et ifosfamide = Phase I-II trial of seraspenide: a suppressor of myelopoiesis protects against cytarabine and ifosfamide monochemotherapy myelotoxicityCARDE, P; CHASTANG, C; GARCIA-GIRALT, E et al.Comptes rendus de l'Académie des sciences. Série 3, Sciences de la vie. 1992, Vol 315, Num 13, pp 545-550, issn 0764-4469Article

Radiotherapy versus combined modality in early stagesSPECHT, L; CARDE, P; MAUCH, P et al.Annals of oncology. 1992, Vol 3, pp S77-S81, issn 0923-7534, SUP4Conference Paper

Causes of death after therapy for early stage Hodgkin's disease entered on EORTC protocolsHENRY-AMAR, M; HAYAT, M; VAN DER SCHUEREN, E et al.International journal of radiation oncology, biology, physics. 1990, Vol 19, Num 5, pp 1155-1157, issn 0360-3016Article

CHIMIOTHERAPIE PREMIERE DANS LES SARCOMES DES PARTIES MOLLES CONSIDEREES COMME INOPERABLES = PRIMARY CHEMOTHERAPY IN INOPERABLE SOFT TISSUE SARCOMASROUESSE J; LE CHEVALIER T; CONTESSO G et al.1983; SEMAINE DES HOPITAUX; ISSN 0037-1777; FRA; DA. 1983; VOL. 59; NO 19; PP. 1441-1444; ABS. FRE/ENG; BIBL. 9 REF.Article

ABVD (8 cycles) versus BEACOPP (4 escalated cycles ≥4 baseline): final results in stage III-IV low-risk Hodgkin lymphoma (IPS 0-2) of the LYSA H34 randomized trialMOUNIER, N; BRICE, P; DELMER, A et al.Annals of oncology. 2014, Vol 25, Num 8, pp 1622-1628, issn 0923-7534, 7 p.Article